| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
26,020,000 |
| Market
Cap: |
245.11(M) |
| Last
Volume: |
6,675 |
Avg
Vol: |
6,656 |
| 52
Week Range: |
$6.48 - $11.61 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Home Health Care |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Fennec Pharmaceuticals is a biopharmaceutical company focused on the development of PEDMARK™ (sodium thiosulfate anhydrous injection) for the prevention of platinum-induced ototoxicity in pediatric cancer patients. Co. has licensed from Oregon Health & Science University intellectual property rights for the use of PEDMARK™ as a chemoprotectant and is developing PEDMARK™ as a protectant against the hearing loss caused by platinum-based anti-cancer agents in children.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
41,667 |
41,667 |
41,667 |
41,667 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
2 |
2 |
2 |
2 |
| Total Buy Transactions |
2 |
2 |
2 |
2 |
| Total Shares Sold |
384,683 |
445,042 |
481,476 |
532,549 |
| Total Sell Value |
$3,266,840 |
$3,836,454 |
$4,152,217 |
$4,642,390 |
| Total People Sold |
4 |
4 |
4 |
4 |
| Total Sell Transactions |
18 |
24 |
31 |
38 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Raykov Rosty |
Chief Executive Officer |
• • – |
2018-08-20 |
4/A |
OE |
$1.44 |
$24,552 |
D/D |
17,050 |
57,790 |
|
- |
|
| Raykov Rosty |
Chief Executive Officer |
• – – |
2018-08-20 |
4 |
OE |
$1.44 |
$24,552 |
D/D |
17,050 |
40,470 |
|
- |
|
| Andrade Robert |
Chief Financial Officer |
• – – |
2018-08-15 |
4 |
OE |
$1.44 |
$24,552 |
D/D |
17,050 |
17,050 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2018-03-28 |
4 |
S |
$11.50 |
$1,683,610 |
D/D |
(146,393) |
1,250,000 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2018-03-28 |
4 |
S |
$11.50 |
$1,683,610 |
I/I |
(146,393) |
1,666,666 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2018-03-27 |
4 |
S |
$11.34 |
$257,497 |
D/D |
(22,707) |
1,396,393 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2018-03-27 |
4 |
S |
$11.34 |
$257,497 |
I/I |
(22,707) |
1,813,059 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2018-03-23 |
4 |
S |
$10.88 |
$38,080 |
D/D |
(3,500) |
1,419,100 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2018-03-23 |
4 |
S |
$10.88 |
$38,080 |
I/I |
(3,500) |
1,835,766 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2018-03-22 |
4 |
S |
$10.76 |
$215,200 |
D/D |
(20,000) |
1,422,600 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2018-03-22 |
4 |
S |
$10.76 |
$215,200 |
I/I |
(20,000) |
1,839,266 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2018-03-21 |
4 |
S |
$10.18 |
$2,140,966 |
D/D |
(210,311) |
1,442,600 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2018-03-21 |
4 |
S |
$10.18 |
$2,140,966 |
I/I |
(210,311) |
1,859,266 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2018-03-20 |
4 |
S |
$9.54 |
$187,343 |
D/D |
(19,383) |
1,652,911 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2018-03-20 |
4 |
S |
$9.54 |
$187,343 |
I/I |
(19,383) |
2,069,577 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2018-03-19 |
4 |
S |
$9.57 |
$1,914 |
D/D |
(200) |
1,672,294 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2018-03-19 |
4 |
S |
$9.57 |
$1,914 |
I/I |
(200) |
2,088,960 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2018-03-16 |
4 |
S |
$9.52 |
$20,182 |
D/D |
(2,120) |
1,672,494 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2018-03-16 |
4 |
S |
$9.52 |
$81,329 |
I/I |
(8,543) |
2,089,160 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2018-03-14 |
4 |
S |
$9.47 |
$128,792 |
I/I |
(13,600) |
2,097,703 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2018-03-13 |
4 |
S |
$9.27 |
$156,978 |
I/I |
(16,934) |
2,111,303 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2018-03-12 |
4 |
S |
$9.50 |
$176,320 |
I/I |
(18,560) |
2,128,237 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2018-03-08 |
4 |
S |
$9.12 |
$91,200 |
I/I |
(10,000) |
2,146,797 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2018-03-06 |
4 |
S |
$9.11 |
$60,126 |
I/I |
(6,600) |
2,156,797 |
|
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2018-03-02 |
4 |
S |
$9.17 |
$183,400 |
I/I |
(20,000) |
2,163,397 |
|
- |
|
268 Records found
|
|
Page 4 of 11 |
|
|
0.15 (1.62%) 
